Marshall Wace, LLP Spdr Ser Tr Spdr S&P Biotech E Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
A detailed history of Marshall Wace, LLP transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Marshall Wace, LLP holds 5,323 shares of XBI stock, worth $489,609. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,323
Previous 311,000
98.29%
Holding current value
$489,609
Previous $28.8 Million
98.18%
% of portfolio
0.0%
Previous 0.04%
Shares
16 transactions
Others Institutions Holding XBI
# of Institutions
927Shares Held
101MCall Options Held
28.4MPut Options Held
33.4M-
Goldman Sachs Group Inc New York, NY12.7MShares$1.17 Billion0.21% of portfolio
-
Jpmorgan Chase & CO New York, NY12.3MShares$1.13 Billion0.1% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A69.23MShares$849 Million2.24% of portfolio
-
Morgan Stanley New York, NY8.02MShares$738 Million0.06% of portfolio
-
Citigroup Inc7.75MShares$713 Million0.45% of portfolio